Immune-related Adverse Events — CAR T-Cell Therapy Guidelines Pocket Guide - Guideline Central

Immune-related Adverse Events — CAR T-Cell Therapy

American Society of Clinical OncologyPublished: November 1, 2021

A PDF version of this Pocket Guide is also available!
$9.95
  • Key Points
  • Key Recommendations
  • Management
    • General Recommendations
    • Tables
      • Cytokine Release Syndrome Recommendations
      • ICANS Recommendations
      • Hemophagocytic Lymphohistiocytosis (HLH) Recommendations
      • Cytopenias Recommendations
      • B-cell Aplasia Recommendations
      • Disseminated Intravascular Coagulation
      • Infections
      • CAR T-cell Therapies


You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.